Skip to main content
. Author manuscript; available in PMC: 2012 Jul 10.
Published in final edited form as: Semin Nucl Med. 2011 Jan;41(1):29–44. doi: 10.1053/j.semnuclmed.2010.08.005

Table 3.

11C-acetate PET clinical trials in prostate cancer37-39,66,80,84-89

Tracer(s) Patient
number		 Disease stage Study
objective		 Sensitivity Specificity Year Group
11C-acetate 30 Early Staging NA NA 2002 Kato T, et al.
11C-acetate 31 Advanced Re-staging 83% NA 2002 Kotzerke J, et al.
11C-acetate 20 Advanced Restaging 75% NA 2006 Sanblom G, et al.
11C-acetate 50 Advanced Re-staging NA NA 2006 Wachter S, et al.
11C-acetate 32 Advanced Restaging 82% NA 2007 Albrecht S, et al.
11C-acetate 12 Advanced Staging NA NA 2009 Seppala J, et al.
11C-acetate, 11C-choline 12 Advanced Staging NA NA 2003 Kotzerke J, et al.
11C-acetate, 18F-FDG 25 (15) Mixed Staging NA NA 2003 Fricke E, et al
11C-acetate, 18F-FDG 22(18) Early Staging NA NA 2002 Oyama N, et al.
11C-acetate, 18F-FDG 46 Advanced Restaging NA NA 2003 Oyama N, et al.
11C-acetate, 18F-FCH 11 (11) Advanced Restaging NA NA 2007 Vees H, et al.